AGLE Aeglea BioTherapeutics Inc.

Note: We have detected that our data provider shows 0 for short interest. Please manually confirm and if different, disregard the short data and short pain data below.

$7.86 +4.8%

124,263 Shares Traded
108,231 Average Volume (last 30 days)

as of December 17, 2018 EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up


Aeglea Bio initiates late-stage study of pegzilarginase in arginase 1 deficiency (SeekingAlpha)

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-46.1%
If Intiated One Month Ago, Shorts Have Realized a Return of:0.38%
If Initiated Five Days ago, Shorts Have Realized a Return of:3.2%
Peer Rising Stocks Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0%
Short Interest0
Float23.38 million
Short Ratio0
Market Cap$188.34 million
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 71%
Insider Percent2.6%

Earnings Stats

PE Ratio -4.2
Dividend Yield 0%

Earnings History For AGLE

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-11-08 Q3 2018-0.41 (1 Estimates) -0.54-0.13
2018-08-09 Q2 2018-0.37 (1 Estimates) -0.46-0.09
2018-05-08 Q1 2018-0.54 (1 Estimates) -0.490.05
2018-03-13 Q4 2017-0.38


200 Day Moving Average $9.3
50 Day Moving Average $8.64
52 Week High $12
52 Week Low $4.86

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ